Close Menu

Gene Codes

Gene Codes has released Sequencher 5.2, the latest version of its DNA sequence data analysis software.

The company is appealing a US District Court's ruling in a suit it filed against the Office of the Chief Medical Examiner of New York, which granted the city's motion for summary judgment.

The judge denied Gene Codes' request for discovery in a suit it filed against the Office of the Chief Medical Officer of New York and granted the city's motion for summary judgment in the case.

Avadis NGS, Genome Trax, Ask Extractor, Journal Trends, GenePattern 3.3.2, Sequencher 5.0, ExPASy

New Products: Jun 28, 2011

Premium

Roche's 454 GS FLX+ system, Gene Codes' Sequencher

Gene Codes claims that New York City's Office of the Medical Examiner violated its contract with the company by providing the FBI with access to trade secrets and confidential information about its DNA-matching software, M-FISys. The city maintains its innocence and has called for the case to be dismissed.

In its suit, Gene Codes alleges New York's Office of Chief Medical Examiner infringed on its software developed to identify victims of the 9/11 attack at Ground Zero from DNA. The city is countersuing.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.